A Clinical Study of Conservative Vs Surgical Treatment of Female Pituitary Microprolactinoma

Yihua YIN,Meijuan WEI,Lingda FENG,Shiqi LI

2008-01-01

Abstract:Objective To compare the effects of conservative and surgical treatments of microprolactinoma in women of reproductive age.Methods A retrospective analysis was conducted in 88 patients with pituitary microp- rolactinoma,who received either conservative treatment with medication(n=26) or surgical treatment(n=62). All the patients were followed up to observe the changes in clinical manifestations and hormonal profiles with the pregnancies and child birth recorded.The effects of the treatments were evaluated in line with the criteria of Peking Union Medical College.Results The overall effective rate of the treatments was 73.9%,and the effective rate was 69.2%with drug treatment and 75.8%with surgical treatment;there was no significant difference between the two treatments.The overall pregnancy rate after treatment was 12/19,with a live birth rate of 10/19.Conserva- tive treatment with medications was associated with a significantly higher live birth rate than surgical treatment (7/8 vs 3/11,P0.05),as well as a significantly higher pregnancy rate.Adverse effects occurred in 53.8%of the patients having conservative treatment with medications,and 24.2%patients undergoing surgical treatment had postoperative complications.Multivariate regression analysis indicated that prolectin recovery within 1 week after medication and prolectin declination by over 20 folds one day after surgery were the independent risk factors for predicting the clinical outcome of the treatments.Conclusion Drug treatment should be the first choice for women planning to have pregnancy,and regular prolectin measurement after treatment is suggested for timely modification of the treatments.The first 3 months following the treatment is the critical period for microprolacti- noma patients who plan to have pregnancies.(Shanghai Med J,2008,31:83-86)